Patrick Michael Reeves, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coxiella burnetii | 6 | 2023 | 37 | 2.090 |
Why?
|
| Q Fever | 6 | 2023 | 37 | 2.070 |
Why?
|
| Bacterial Vaccines | 5 | 2022 | 403 | 1.250 |
Why?
|
| Heterocyclic Compounds | 3 | 2019 | 249 | 0.860 |
Why?
|
| Proto-Oncogene Proteins c-abl | 3 | 2010 | 146 | 0.660 |
Why?
|
| Immunity, Cellular | 2 | 2020 | 1607 | 0.580 |
Why?
|
| Receptors, CXCR4 | 2 | 2019 | 726 | 0.550 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2015 | 122 | 0.500 |
Why?
|
| Clathrin | 1 | 2015 | 267 | 0.480 |
Why?
|
| Endocytosis | 2 | 2015 | 985 | 0.480 |
Why?
|
| Drug Discovery | 2 | 2017 | 1058 | 0.430 |
Why?
|
| Variola virus | 1 | 2010 | 11 | 0.390 |
Why?
|
| Virion | 2 | 2010 | 433 | 0.380 |
Why?
|
| Monkeypox virus | 1 | 2010 | 48 | 0.380 |
Why?
|
| Virus Release | 1 | 2010 | 39 | 0.380 |
Why?
|
| Immunity, Innate | 3 | 2023 | 2958 | 0.360 |
Why?
|
| src-Family Kinases | 2 | 2010 | 551 | 0.360 |
Why?
|
| Paclitaxel | 1 | 2017 | 1708 | 0.360 |
Why?
|
| Vaccines | 1 | 2017 | 822 | 0.330 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2022 | 880 | 0.300 |
Why?
|
| Flow Cytometry | 1 | 2017 | 5974 | 0.290 |
Why?
|
| Ovarian Neoplasms | 3 | 2019 | 4838 | 0.270 |
Why?
|
| Poxviridae | 1 | 2005 | 37 | 0.260 |
Why?
|
| GPI-Linked Proteins | 2 | 2018 | 434 | 0.250 |
Why?
|
| T-Lymphocytes | 3 | 2022 | 10180 | 0.240 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2018 | 404 | 0.230 |
Why?
|
| Antigens, Bacterial | 2 | 2019 | 1171 | 0.220 |
Why?
|
| Benzylamines | 3 | 2019 | 223 | 0.220 |
Why?
|
| Vaccinia virus | 3 | 2010 | 349 | 0.200 |
Why?
|
| Mesothelioma | 2 | 2018 | 818 | 0.180 |
Why?
|
| Piperazines | 2 | 2010 | 2488 | 0.170 |
Why?
|
| HLA-DR Antigens | 1 | 2020 | 645 | 0.160 |
Why?
|
| Cancer Vaccines | 2 | 2018 | 1023 | 0.160 |
Why?
|
| Pyrimidines | 3 | 2010 | 2942 | 0.160 |
Why?
|
| Vaccinia | 2 | 2010 | 76 | 0.150 |
Why?
|
| Mice | 12 | 2022 | 81183 | 0.150 |
Why?
|
| Antibodies, Bacterial | 2 | 2022 | 1470 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 6386 | 0.150 |
Why?
|
| Cell Growth Processes | 1 | 2017 | 399 | 0.140 |
Why?
|
| Chemokine CXCL12 | 1 | 2019 | 464 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11524 | 0.140 |
Why?
|
| Drug Synergism | 2 | 2018 | 1792 | 0.140 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 412 | 0.140 |
Why?
|
| Arrestins | 1 | 2015 | 74 | 0.130 |
Why?
|
| Actins | 3 | 2010 | 2121 | 0.130 |
Why?
|
| Animals | 15 | 2023 | 168757 | 0.120 |
Why?
|
| Immunomodulation | 1 | 2018 | 541 | 0.120 |
Why?
|
| Systems Biology | 1 | 2017 | 469 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 2 | 2022 | 2012 | 0.120 |
Why?
|
| Sphingosine | 1 | 2015 | 307 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2010 | 5535 | 0.110 |
Why?
|
| Dihydropyridines | 1 | 2012 | 67 | 0.110 |
Why?
|
| Benzamides | 2 | 2010 | 1379 | 0.110 |
Why?
|
| Xenopus | 1 | 2014 | 712 | 0.110 |
Why?
|
| Immunologic Memory | 1 | 2019 | 1348 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2133 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 21827 | 0.100 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2012 | 314 | 0.100 |
Why?
|
| Monocytes | 1 | 2020 | 2596 | 0.090 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 3586 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 9734 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2017 | 738 | 0.090 |
Why?
|
| Immune Tolerance | 1 | 2019 | 2258 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 1917 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2015 | 3128 | 0.090 |
Why?
|
| Antibodies | 1 | 2017 | 2460 | 0.090 |
Why?
|
| beta Catenin | 1 | 2014 | 1059 | 0.080 |
Why?
|
| Enzyme-Linked Immunospot Assay | 2 | 2019 | 130 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2015 | 4204 | 0.080 |
Why?
|
| 3T3 Cells | 1 | 2010 | 1101 | 0.080 |
Why?
|
| Guinea Pigs | 2 | 2022 | 1386 | 0.080 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 3703 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1119 | 0.080 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 4251 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 2716 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 10943 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 2183 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16689 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4386 | 0.070 |
Why?
|
| Poxviridae Infections | 1 | 2005 | 12 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5442 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2012 | 3002 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 1294 | 0.060 |
Why?
|
| Humans | 16 | 2023 | 744343 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 1637 | 0.060 |
Why?
|
| Genes, bcl-2 | 1 | 2023 | 122 | 0.060 |
Why?
|
| Chimerism | 1 | 2023 | 158 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 1866 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9438 | 0.050 |
Why?
|
| Interferon-gamma | 2 | 2019 | 3206 | 0.050 |
Why?
|
| Female | 9 | 2020 | 380194 | 0.050 |
Why?
|
| Primates | 1 | 2023 | 545 | 0.050 |
Why?
|
| Dendritic Cells | 2 | 2014 | 2725 | 0.050 |
Why?
|
| Convalescence | 1 | 2019 | 105 | 0.040 |
Why?
|
| Peptides | 2 | 2022 | 4409 | 0.040 |
Why?
|
| Cell Movement | 1 | 2010 | 5217 | 0.040 |
Why?
|
| Virus Replication | 1 | 2006 | 2534 | 0.040 |
Why?
|
| Cell Line | 2 | 2010 | 15997 | 0.040 |
Why?
|
| Transplantation Tolerance | 1 | 2023 | 617 | 0.040 |
Why?
|
| Histocompatibility Testing | 1 | 2019 | 741 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2006 | 3420 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2023 | 1904 | 0.040 |
Why?
|
| Cytokines | 2 | 2023 | 7322 | 0.030 |
Why?
|
| Cricetulus | 1 | 2018 | 816 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 23403 | 0.030 |
Why?
|
| CHO Cells | 1 | 2018 | 1406 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 1475 | 0.030 |
Why?
|
| Adaptor Protein Complex mu Subunits | 1 | 2014 | 20 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 2455 | 0.030 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2014 | 43 | 0.030 |
Why?
|
| Immunization | 1 | 2019 | 1256 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2012 | 19229 | 0.030 |
Why?
|
| Cricetinae | 1 | 2018 | 2472 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3200 | 0.030 |
Why?
|
| Pyridines | 1 | 2005 | 2825 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 21683 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2019 | 1381 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 1366 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 4420 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2004 | 4217 | 0.030 |
Why?
|
| Proteins | 1 | 2006 | 6103 | 0.020 |
Why?
|
| Survival Rate | 1 | 2005 | 12788 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2012 | 2255 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 18029 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 708 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 2916 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13102 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 3772 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4479 | 0.020 |
Why?
|
| Heart | 1 | 2020 | 4467 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 3129 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 7799 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8642 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2014 | 2440 | 0.020 |
Why?
|
| Actin-Related Protein 2 | 1 | 2004 | 40 | 0.020 |
Why?
|
| Actin-Related Protein 3 | 1 | 2004 | 48 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2019 | 9146 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2004 | 88 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6622 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9959 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6895 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9386 | 0.010 |
Why?
|
| Algorithms | 1 | 2022 | 13881 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 3768 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7181 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10252 | 0.010 |
Why?
|
| Viral Vaccines | 1 | 2006 | 636 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 2004 | 532 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 2004 | 749 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2006 | 2225 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1434 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2006 | 1900 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 1623 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1364 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 3701 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2004 | 1050 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14557 | 0.010 |
Why?
|
| Proteome | 1 | 2006 | 1799 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2012 | 11483 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 2866 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 8436 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4462 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 9727 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 163280 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 213383 | 0.000 |
Why?
|
| Male | 1 | 2019 | 350118 | 0.000 |
Why?
|